| Interaction between the human immunodeficiency virus type 1 Gag matrix domain and phosphatidylinositol-(4, 5)-bisphosphate is essential for efficient gag membrane binding V Chukkapalli, IB Hogue, V Boyko, WS Hu, A Ono Journal of virology 82 (5), 2405-2417, 2008 | 274 | 2008 |
| Opposing mechanisms involving RNA and lipids regulate HIV-1 Gag membrane binding through the highly basic region of the matrix domain V Chukkapalli, SJ Oh, A Ono Proceedings of the National Academy of Sciences 107 (4), 1600-1605, 2010 | 255 | 2010 |
| Molecular determinants that regulate plasma membrane association of HIV-1 Gag V Chukkapalli, A Ono Journal of molecular biology 410 (4), 512-524, 2011 | 143 | 2011 |
| Lipids at the interface of virus–host interactions V Chukkapalli, NS Heaton, G Randall Current opinion in microbiology 15 (4), 512-518, 2012 | 114 | 2012 |
| Positive-strand RNA viruses stimulate host phosphatidylcholine synthesis at viral replication sites J Zhang, Z Zhang, V Chukkapalli, JA Nchoutmboube, J Li, G Randall, ... Proceedings of the National Academy of Sciences 113 (8), E1064-E1073, 2016 | 90 | 2016 |
| Evidence in support of RNA-mediated inhibition of phosphatidylserine-dependent HIV-1 Gag membrane binding in cells V Chukkapalli, J Inlora, GC Todd, A Ono Journal of virology 87 (12), 7155-7159, 2013 | 86 | 2013 |
| Gag localization and virus-like particle release mediated by the matrix domain of human T-lymphotropic virus type 1 Gag are less dependent on phosphatidylinositol-(4, 5 … J Inlora, V Chukkapalli, D Derse, A Ono Journal of virology 85 (8), 3802-3810, 2011 | 84 | 2011 |
| Impact of cachexia on outcomes in aggressive lymphomas R Karmali, T Alrifai, IAM Fughhi, R Ng, V Chukkapalli, P Shah, S Basu, ... Annals of hematology 96, 951-956, 2017 | 40 | 2017 |
| Daclatasvir inhibits hepatitis C virus NS5A motility and hyper-accumulation of phosphoinositides V Chukkapalli, KL Berger, SM Kelly, M Thomas, A Deiters, G Randall Virology 476, 168-179, 2015 | 40 | 2015 |
| Assembly and replication of HIV-1 in T cells with low levels of phosphatidylinositol-(4, 5)-bisphosphate K Monde, V Chukkapalli, A Ono Journal of virology 85 (7), 3584-3595, 2011 | 39 | 2011 |
| Interaction between HIV-1 Gag matrix domain and phosphatidylinositol-(4, 5)-bisphosphate is essential for efficient Gag-membrane binding V Chukkapalli, IB Hogue, V Boyko, WS Hu, A Ono J. Virol 82, 2405-2417, 2008 | 26 | 2008 |
| GSK-3β inhibitor, 9-ING-41, reduces cell viability and halts proliferation of B-cell lymphoma cell lines as a single agent and in combination with novel agents R Karmali, V Chukkapalli, LI Gordon, JA Borgia, A Ugolkov, AP Mazar, ... Oncotarget 8 (70), 114924, 2017 | 18 | 2017 |
| Metabolic changes associated with metformin potentiates Bcl-2 inhibitor, Venetoclax, and CDK9 inhibitor, BAY1143572 and reduces viability of lymphoma cells V Chukkapalli, LI Gordon, P Venugopal, JA Borgia, R Karmali Oncotarget 9 (30), 21166, 2018 | 17 | 2018 |
| Molecular determinants directing HIV-1 Gag assembly to virus-containing compartments in primary macrophages J Inlora, V Chukkapalli, S Bedi, A Ono Journal of Virology 90 (19), 8509-8519, 2016 | 15 | 2016 |
| Impact of treatment variability on survival in immuno‐competent and immuno‐compromised patients with primary central nervous lymphoma R Karmali, C Nabhan, AM Petrich, J Raizer, D Peace, R Lukas, LI Gordon, ... British Journal of Haematology 177 (1), 72-79, 2017 | 10 | 2017 |
| Hepatitis C virus replication compartment formation: mechanism and drug target V Chukkapalli, G Randall Gastroenterology 146 (5), 1164-1167, 2014 | 8 | 2014 |
| Biologic pathways of cancer-cachexia syndrome (muscle and fat wasting) impact clinical outcomes in aggressive B-cell non-Hodgkin lymphoma R Karmali, V Chukkapalli, P Shah, T Alrifai, IA Fughhi, R Ng, S Basu, ... Blood 128 (22), 1771, 2016 | 1 | 2016 |
| Induction of receptor tyrosine kinase signaling by sera from patients with lung adenocarcinoma GC Lobato, JD Fialkoff, I Tarhoni, N Lund, V Chukkapalli, S Sayidine, ... Cancer Research 77 (13_Supplement), 4665-4665, 2017 | | 2017 |
| METABOLIC CHANGES ASSOCIATED WITH METFORMIN POTENTIATES ANTI‐BCL‐2 INHIBITOR, ABT‐199, AND CDK9 INHIBITOR, BAY‐1143572 AND REDUCES VIABILITY OF LYMPHOMA CELLS R Karmali, V Chukkapalli, LI Gordon, JA Borgia Hematological Oncology 35, 401-402, 2017 | | 2017 |
| GSK‐3ß INHIBITOR, 9‐ING‐41 REDUCES CELL VIABILITY AND HALTS PROLIFERATION OF B‐CELL LYMPHOMA R Karmali, V Chukkapalli, B Pro, JA Borgia, A Mazar, A Ugolkov, FJ Giles Hematological Oncology 35, 400-402, 2017 | | 2017 |
Ian B. HogueAssistant Professor, Arizona State UniversityVerified email at asu.edu
